NIH's Defense Deal: A Troubling Blending of Research Agendas The National Institutes of Health's (NIH) decision to allocate a portion of its budget for Department of Defense research has sparked intense debate, raising questions about the motivations behind this move and its implications for biomedical research.
The agreement sets aside money from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) budget to fund medical countermeasures against pandemic influenza, CBRN threats, and emerging infectious diseases.
The NIH is struggling to issue sufficient grants for its existing research initiatives, despite being allocated $6. 6 billion in 2026.